مشخصات مقاله | |
ترجمه عنوان مقاله | SOX2 در توسعه و زیست شناسی سرطان |
عنوان انگلیسی مقاله | SOX2 in development and cancer biology |
انتشار | مقاله سال 2019 |
تعداد صفحات مقاله انگلیسی | 9 صفحه |
هزینه | دانلود مقاله انگلیسی رایگان میباشد. |
پایگاه داده | نشریه الزویر |
نوع نگارش مقاله |
مقاله مروری (Review Article) |
مقاله بیس | این مقاله بیس نمیباشد |
نمایه (index) | Master ISC – MedLine – Scopus – Master Journals List – JCR |
نوع مقاله | ISI |
فرمت مقاله انگلیسی | |
ایمپکت فاکتور(IF) |
8.752 در سال 2018 |
شاخص H_index | 134 در سال 2019 |
شاخص SJR | 3.259 در سال 2018 |
شناسه ISSN | 1044-579X |
شاخص Quartile (چارک) | Q1 در سال 2018 |
مدل مفهومی | ندارد |
پرسشنامه | ندارد |
متغیر | ندارد |
رفرنس | دارد |
رشته های مرتبط | پزشکی، زیست شناسی |
گرایش های مرتبط | پزشکی مولکولی، ایمنی شناسی پزشکی، علوم سلولی و مولکولی، خون و انکولوژی |
نوع ارائه مقاله |
ژورنال |
مجله | سمینارهای زیست شناسی سرطان – Seminars In Cancer Biology |
دانشگاه | Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany |
کلمات کلیدی | سرطان، Sox2، توسعه، تومور، سلول بنیادی |
کلمات کلیدی انگلیسی | Cancer، Sox2، Development، Tumor، Stem cell |
شناسه دیجیتال – doi |
https://doi.org/10.1016/j.semcancer.2019.08.007 |
کد محصول | E13024 |
وضعیت ترجمه مقاله | ترجمه آماده این مقاله موجود نمیباشد. میتوانید از طریق دکمه پایین سفارش دهید. |
دانلود رایگان مقاله | دانلود رایگان مقاله انگلیسی |
سفارش ترجمه این مقاله | سفارش ترجمه این مقاله |
فهرست مطالب مقاله: |
Abstract
1- Introduction 2- SOX2 in development 3- The role of SOX2 in embryonic and adult stem cells 4- The role of SOX2 in disease and cancer 5- Conclusions and future perspectives References |
بخشی از متن مقاله: |
Abstract The transcription factor SOX2 is essential for embryonic development and plays a crucial role in maintaining the stemness of embryonic cells and various adult stem cell populations. On the other hand, dysregulation of SOX2 expression is associated with a multitude of cancer types and it has been shown that SOX2 positively affects cancer cell traits such as the capacity to proliferate, migrate, invade and metastasize. Moreover, there is growing evidence that SOX2 mediates resistance towards established cancer therapies and that it is expressed in cancer stem cells. These findings indicate that studying the role of SOX2 in the context of cancer progression could lead to the development of new therapeutic options. In this review, the current knowledge about the role of SOX2 in development, maintenance of stemness, cancer progression and the resistance towards cancer therapies is summarized. Introduction In 1990, a new transcription factor with a distinctive DNA-binding domain was described to be involved in testis determination. The gene encoding for this protein was found to be located on the sex-determining region of the Y chromosome and was therefore termed sexdetermining region Y (SRY) gene [1,2]. The Sry protein binds to specific DNA sequences with its high-mobility-group (HMG) domain. Since its discovery a new gene family has been established on the basis of sequence similarities to this HMG domain (Fig. 1). The so-called Sry-related HMG box (SOX) proteins contain an HMG domain with at least 50% sequence similarity to the HMG domain of Sry. Up to the present day, 20 different SOX genes have been found in the murine and human genome which in turn have been divided into eight subgroups based on sequence identity and similar functions [3,4]. In this review, we will focus on SOX2, a member of the SOXB1 subgroup. Among all SOX genes, SOX2 is probably the most recognized due to its role in reprogramming somatic cells into induced pluripotent stem cells (iPSCs) [5]. The human SOX2 gene is situated on chromosome 3 at the position q26.3–27 and encodes for a protein of 317 amino acids [6]. The structural centerpiece of SOX2 is its HMG domain that is highly conserved among species. Apart from binding to specific DNA consensus sequences, this domain also contains a nuclear localization and a nuclear export signal. The function of the C-terminal transactivation domain is to recognize and bind the promoters of target genes and by doing so activating or repressing gene expression [7]. |